Thiago Montes Fidale

Prof. Thiago Montes Fidale

Ibiotec / Medicina, Universidade Federal de Catalão, Catalão, Goiás, Brazil
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Journal of Strength & Conditioning Research
Verified
Journal Article
Closed access
FSFabricio H.O. Silva
Fabricio H.O. Silva
FAFranciel J. Arantes
Franciel J. Arantes
FGFabio C. Gregorio
Fabio C. Gregorio
FSFhillipe R.A. Santos
Fhillipe R.A. Santos
TFThiago Montes Fidale
Thiago Montes Fidale
FLFrederico B. Lizardo
Frederico B. Lizardo
Silva, FHO, Arantes, FJ, Gregorio, FC, Santos, FRA, Fidale, TM, Bérzin, F, Bigaton, DR, and Lizardo, FB. Comparison of the electromyographic activity of the trunk and rectus femoris muscles during traditional crunch and exercise using the 5-minute Shaper device. J Strength Cond Res 34(1): 1–10, 2020—Different training devices are available to trigger greater activation of the abdominal muscles compared with that achieved during traditional abdominal exercises. This study aimed to compare the electromyographic (EMG) activity of the upper and lower rectus abdominis, external oblique abdominis, erector spinae, and rectus femoris (RF) muscles during traditional crunch and exercise using the 5-minute Shaper device. A convenience sample of 15 healthy men (mean ± SD ; age: 23.65 ± 4.49 years, body fat percentage: 14.26 ± 3.56%) was selected. All men regularly participated in physical activity. Electromyographic data were collected for 5 repetitions of each abdominal exercise (traditional crunch and exercise using the 5-minute Shaper device at beginner, intermediate, advanced, and extreme levels) in a randomized and counterbalanced manner. Data were collected using simple differential surface electrodes and analyzed using repeated-measures analysis of variance ( p < 0.05). Electromyographic signals were quantified using a root-mean-square analysis and normalized using the maximum voluntary isometric contraction. Traditional crunch produced greater or similar EMG activity in the abdominal muscles and minimized RF activity compared to the 5-minute Shaper device, hence, traditional crunch is preferred for training, especially for individuals with weak abdominal musculature and lower back problems. Therefore, the use of the 5-minute Shaper device may be questioned when it is intended to intensify the activity of the abdominal muscles; however, this apparatus may be used if greater variations in training are desired, depending on individual preferences.

17 January 2018 in Frontiers in Physiology
Verified
Journal Article
Open access
PDF file
TFThiago Montes Fidale
Thiago Montes Fidale
HAHanna Karen Antunes
Hanna Karen Antunes
LSLuciano Alex dos Santos
Luciano Alex dos Santos
FSFernanda Rodrigues de Souza
Fernanda Rodrigues de Souza
SDSimone R. Deconte
Simone R. Deconte
ERElmiro S. Resende
Elmiro S. Resende
Cardiotoxicity is one of the most significant adverse effects of the oncologic treatment with doxorubicin, which is responsible for a substantial morbid and mortality. The occurrence of heart failure with ventricular dysfunction may lead to severe cardiomyopathy and ultimately to death. Studies have focused on the effects of leucine supplementation as a strategy to minimize or revert the clinical condition of induced proteolysis by several clinical onsets. However, the impact of leucine supplementation in heart failure induced by doxorubicin is unknown. Therefore, the objective of this work is to evaluate the effects of leucine supplementation on the cardiotoxicity in the heart of rats treated with doxorubicin. Rats treated with a 7.5 mg/kg cumulative dose of doxorubicin for 14 days presented a dilatation of the left ventricle (LV), and a reduction of the ejection fraction (FE). The 5% supplementation of leucine in the rats' food prevented the malfunctioning of the LV when administered with doxorubicin. Some alterations in the extracellular matrix remodeling were confirmed by the increase of collagen fibers in the doxorubicin group, which did not increase when the treatment was associated with leucine supplementation. Leucine attenuates heart failure in this experimental model with doxorubicin. Such protection is followed by the maintenance of interstitial collagen fibers.

1 April 2018 in Medicine
Verified
Journal Article
Open access
Leonardo RoeverLeonardo Roever
Leonardo Roever
ERElmiro Santos Resende
Elmiro Santos Resende
ADAngélica Lemos Debs Diniz
Angélica Lemos Debs Diniz
NPNilson Penha-Silva
Nilson Penha-Silva
JOJoão Lucas O’cOnnell
João Lucas O’cOnnell
GBGiuseppe Biondi-Zoccai
Giuseppe Biondi-Zoccai
The metabolic syndrome is composed of several cardiovascular risk factors and has a high prevalence throughout the world. However, there are no systematic analyses or well-conducted meta-analyses to evaluate the relationship between metabolic syndrome and stroke. The aim of this study is to examine this association of metabolic syndrome with stroke in different ages and sex. The update systematic review and meta-analysis will be conducted using published studies that will be identified from electronic databases (i.e., PubMed, EMBASE, Web of Science, and Google Scholar. Studies that examined the association between metabolic syndrome and stroke, had a longitudinal or prospective cohort design, were conducted among in adults aged 40 to 70 years, provided sufficient data for calculating ORs or relative risk with a 95% CI, were published as original articles written in English or other languages, and have been published until December 2017 will be included. Study selection, data collection, quality assessment, and statistical syntheses will be conducted based on discussions among investigators. Ethics approval was not required for this study because it was based on published studies. The results and findings of this study will be submitted and published in a scientific peer-reviewed journal. The findings from this study could be useful for assessing metabolic syndrome risk factors in stroke, and determining approaches for prevention of stroke in the future.

18 July 2022 in Sports Engineering
Verified
Journal Article
Closed access
PDF file
BSBarbara Gama da Silva
Barbara Gama da Silva
IMIsabela Marques
Isabela Marques
DFDaniel Antonio Furtado
Daniel Antonio Furtado
SSSilvio Soares dos Santos
Silvio Soares dos Santos
TFThiago Montes Fidale
Thiago Montes Fidale
APAdriano Alves Pereira
Adriano Alves Pereira

1 June 2018 in Medicine
Verified
Journal Article
Open access
Leonardo RoeverLeonardo Roever
Leonardo Roever
ERElmiro Santos Resende
Elmiro Santos Resende
ADAngélica Lemos Debs Diniz
Angélica Lemos Debs Diniz
NPNilson Penha-Silva
Nilson Penha-Silva
JOJoão Lucas O’cOnnell
João Lucas O’cOnnell
GBGiuseppe Biondi-Zoccai
Giuseppe Biondi-Zoccai
The prevalence of metabolic syndrome (MetS) and MetS-related stroke is set to increase dramatically in coming decades. MetS is a complex disease that includes endothelial dysfunction, insulin resistance, diabetes, hypertension, ectopic obesity, and dyslipidaemia and an increased risk of cardiovascular events. One function of high-density lipoprotein (HDL) cholesterol (HDL-C) is the cholesterol-efflux pathway, which is the pathway where cholesterol is removed from macrophages within the arterial walls back into the bloodstream and out to the liver. As one of the key functions of HDL, their hypothesis was that if they could measure HDL-C-efflux capacity, they would have a better handle on the role of HDL in atherosclerosis. However, there are no systematic analyses or well-conducted meta-analyses to evaluate the relationship between HDL-C functionality and MetS. The aim of this study is to examine this association of HDL-C functionality with MetS in different ages and sex. The update systematic review and meta-analysis will be conducted using published studies that will be identified from electronic databases (i.e., PubMed, EMBASE, Web of Science, and Google Scholar). Studies that examined the association between HDL-C functionality and MetS; focused on cohort, case-control, and cross-sectional studies; were conducted among in adults aged 40 to 70 years; provided sufficient data for calculating odds ratio or relative risk with a 95% confidence interval; were published as original articles written in English or other languages; and have been published until January 2018 will be included. Study selection, data collection, quality assessment, and statistical syntheses will be conducted based on discussions among investigators. Ethics approval was not required for this study because it was based on published studies. The results and findings of this study will be submitted and published in a scientific peer-reviewed journal. Trial registration number: PROSPERO (CRD42018083465).

20 November 2018 in Frontiers in Physiology
Verified
Journal Article
Open access
PDF file
TFThiago Montes Fidale
Thiago Montes Fidale
HAHanna Karen Antunes
Hanna Karen Antunes
Leonardo RoeverLeonardo Roever
Leonardo Roever
AGAlexandre Gonçalves
Alexandre Gonçalves
GPGuilherme Puga
Guilherme Puga
ERElmiro Santos Resende
Elmiro Santos Resende
Leucine is a regulator of protein metabolism in vivo and information on its action on effort tolerance of both animals and humans with hyperthyroidism is scarce. The objective of the present study was to verify the influence of leucine supplementation on the effort tolerance of Wistar rats with experimental hyperthyroidism. 40 animals were divided into four groups of ten: control (C), hormone (H), leucine (L), and hormone + leucine (HL). Hyperthyroidism was induced by daily administration of 20 μ⋅g100 g-1 of levothyroxine sodium in aqueous suspension by gavage. Leucine was supplemented by adding 5% of the amino acid to the conventional feed. The animals’ blood was collected by cardiac puncture to analyze TSH, T4, and T3 levels. The effort tolerance was determined by the swimming test with a 7% load attached to animals’ tails. Statistical analysis was performed using the Shapiro-Wilk normality test, followed by the analysis of variance (ANOVA) of repeated measures of two factors (treatment × time) and Tukey post hoc, with a significance level of p < 0.05. Administering thyroid hormone increased the swimming performance of rats after 14 and 21 days, but with a drop in performance at 28 days. The HL group, on the other hand, had a significantly higher swimming performance compared to the other groups after 28 days of treatment. Leucine supplementation associated with the experimental model of hyperthyroidism improved the performance of rats in a swimming test after 28 days of treatment.